2021
DOI: 10.1080/00365521.2021.2018491
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn’s disease; the Sensitivity to Change (STOC) study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 27 publications
0
1
0
Order By: Relevance
“…There were also no adverse events. The authors concluded that PCC is useful to assess changes in mucosal disease activity in CD patients [17].…”
Section: Panenteric Capsule Endoscopy In Adults With Inflammatory Bow...mentioning
confidence: 99%
“…There were also no adverse events. The authors concluded that PCC is useful to assess changes in mucosal disease activity in CD patients [17].…”
Section: Panenteric Capsule Endoscopy In Adults With Inflammatory Bow...mentioning
confidence: 99%
“…Volkers et al explored the endoscopic response to infliximab in 22 patients using PCC. They gave the capsule before, 8 and 12 weeks after treatment; as a result, 27% of patients observed endoscopic remission and another 50% observed endoscopic response [ 86 ]. Similarly, a prospective study of patients treated with Vedolizumab undergoing a PCC exam (before treatment initiation, week 14 and 52 of therapy) is being currently conducted [ 87 ].…”
Section: Monitoringmentioning
confidence: 99%